Labtests

What Labtests does

Labtests, operating commercially as Awanui Labs, is a New Zealand-based community pathology provider delivering clinical laboratory and diagnostic testing services across the country. Founded in 2009 and headquartered in Wellington with regional hubs in Auckland (North) and Canterbury (South), the company runs a nationwide network of physical collection centres, supported by home-visit specimen collection and courier pickup services for healthcare referrers. Its core technology stack is conventional medical-laboratory diagnostics — pathology, blood tests, and specialised screening — augmented by online booking, a self-requested consumer platform (BODYiQ), and a domestically produced non-invasive prenatal screening service (Illumiscreen).

The business serves three horizontal customer segments. The primary segments are individual patients accessing tests via collection centres or the BODYiQ self-serve platform, and healthcare referrers — GPs, specialists, and hospitals — who order tests and rely on Labtests for courier logistics, consumable supply, and a digital specimen collection guide. A secondary commercial segment covers employers, research organisations, and corporate clients through drug testing, clinical trial support, and sexual health testing. Revenue is generated through publicly funded healthcare reimbursement for referred tests, direct self-pay via BODYiQ, and commercial fees for workplace and research services. Distribution is omnichannel: physical collection centres, home visits, courier logistics, and a self-serve digital platform, with marketing primarily via the company website, Facebook, and a healthcare-professional newsletter (The Scope).

Name

Labtests

Legal name

Awanui Labs

Website

https://labtests.co.nz

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Labtests (Awanui Labs) is a New Zealand-based community pathology provider operating a national network of collection centres, home-visit services, and the BODYiQ self-requested testing platform, serving patients, GPs and specialists, and commercial clients.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

Keywords

• Community pathology services
• Diagnostic laboratory testing
• Blood test collection centres
• Prenatal screening services
• Self-requested lab testing

Headquarters

HQ city

Wellington

HQ country

New Zealand

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Clinical Laboratory Testing Services: Diagnostic laboratory testing services for patients referred by healthcare providers (GPs, specialists, hospitals). Services are funded through public healthcare systems and private patient payments.
2. Self-Pay Testing: Direct-to-consumer testing through BODYiQ platform where patients pay out-of-pocket for self-requested tests without healthcare referral.
3. Commercial Testing Services: Drug testing, clinical trials support, and sexual health testing services for commercial clients including employers and research organisations.
4. Prenatal Screening: Illumiscreen non-invasive prenatal testing service for expectant mothers.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Labtests operates a national network of medical laboratory collection centres across New Zealand delivering community pathology and clinical diagnostic testing services. The company serves patients primarily through healthcare provider referrals (GPs, specialists, hospitals) and provides supplementary direct-to-consumer testing through the BODYiQ self-requested platform, specialised prenatal screening via Illumiscreen, and commercial services including drug testing, sexual health screening, and clinical trials support.

Product overview

Awanui Labs operates as a network of medical laboratory collection centres across New Zealand providing diagnostic testing services. The company offers a portfolio of products including BODYiQ, a self-requested testing platform enabling individuals to book lab tests online without GP referral, and Illumiscreen, a non-invasive prenatal screening service. Commercial services include clinical trials support, drug testing, sexual health testing, and wellness testing. Services are delivered through a network of collection centres with online booking capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• BODYiQ: Awanui Labs' self-requested testing platform for consumers to book lab tests online without a doctor's referral
• Illumiscreen

Products and services

• BODYiQ self-requested testing platform Online platform that allows individuals to book, manage, and pay for their own laboratory tests without needing a GP or specialist referral.
• Illumiscreen non-invasive prenatal screening Non-invasive prenatal screening (NIPT) service for expectant mothers; the only non-invasive prenatal screening performed in New Zealand.
• Collection Centre Services Physical collection centres across New Zealand providing specimen collection services for patients referred by GPs, specialists, or self-requesting via BODYiQ.
• Clinical Trials & Studies laboratory support Laboratory testing services for clinical trials and research studies conducted for commercial clients such as pharmaceutical companies and CROs.
• Drug Testing services Drug testing services for commercial and corporate clients, including workplace drug screening programmes.
• Sexual Health Testing services Sexual health screening services offered to commercial clients and individual patients.
• Wellness Testing General wellness and health check testing services made available through the BODYiQ self-requested platform.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Sonic Healthcare: ASX-listed global pathology/radiology operator with established New Zealand laboratory operations. Closest like-for-like peer in business model, scope of services, and geographic exposure.
• Australian Clinical Labs: ASX-listed Australian pathology provider offering community and hospital lab services. Comparable in patient/referrer mix, commercial services, and specialty testing focus.
• Healius: ASX-listed Australian operator of community pathology (Laverty, QML, Dorevitch) and diagnostic services. Closely comparable in community-focused pathology model and referrer-driven GTM.

Broad incumbents

• SYNLAB: European-headquartered global clinical laboratory network with clinical trial and specialty testing services. Comparable in central-lab operations and clinical trial support, but at much larger scale and broader geographic footprint.
• Laboratory Corporation of America (Labcorp): US-listed global clinical laboratory network with routine diagnostics, specialty testing, and clinical trial services. Comparable in commercial services portfolio and central-lab model, at significantly larger scale.
• Quest Diagnostics: US-listed national clinical laboratory offering routine, esoteric, and clinical trial testing. Comparable in service breadth (including prenatal screening and commercial drug testing) but far larger and US-focused.
• LifeLabs: Canada's largest community lab operator, offering routine and specialty diagnostics across a single national market. Comparable in collection-centre-heavy model and national community pathology mandate.

Regional players

• Canterbury Health Laboratories: Public hospital laboratory serving the Canterbury/West Coast region of NZ. Operates as a regional public-sector comparator in the same geography, though funded differently.
• Medlab Central: New Zealand regional community pathology provider operating in the lower North Island. Comparable in community pathology mandate and NZ-specific regulatory regime, but with smaller geographic reach.

Others

• International Accreditation New Zealand (IANZ): NZ accreditation body for laboratories and diagnostic services. Not a competitor, but a relevant ecosystem participant whose accreditation framework governs Awanui Labs' service quality requirements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/awanuilabsnorth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labtests